Liquid Biopsy Market was valued at USD 5.7 Billion in 2022 and is projected to reach USD 13.5 Billion by 2030, growing at a CAGR of 12.5% from 2024 to 2030.
The liquid biopsy market was valued at approximately $5.4 billion in 2022, with an expected compound annual growth rate (CAGR) of around 23.5% from 2023 to 2030. This robust growth is driven by the increasing prevalence of cancer and the rising demand for non-invasive diagnostic methods. Liquid biopsy offers a less invasive alternative to traditional biopsy techniques, making it an attractive option for both patients and healthcare providers. As technological advancements continue to improve the accuracy and efficiency of liquid biopsies, the market is projected to expand significantly over the coming years. The innovation in assay development and the growing number of clinical applications are key factors contributing to this growth trend.
Emerging markets are presenting substantial opportunities for expansion, particularly in regions with increasing healthcare infrastructure and rising awareness about advanced diagnostic tools. Asia-Pacific, Latin America, and the Middle East are seeing a surge in demand for liquid biopsy solutions as these regions experience economic growth and enhancements in medical technology. The integration of liquid biopsy in personalized medicine and its potential in early cancer detection are expected to drive market adoption and development. As these emerging markets continue to mature and invest in advanced healthcare technologies, they are likely to become significant contributors to the overall market growth.
Get an In-Depth Research Analysis of the Global Liquid Biopsy Market Size And Forecast [2025-2032]
Biocept
Qiagen
Roche Diagnostics
Bio-Rad Laboratories
Myriad Genetics
Menarini-Silicon Biosystems
Trovagene
Guardant Health
Mdxhealth
Genomic Health
Raindance Technologies
Thermo Fisher Scientific
Illumina
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Liquid Biopsy Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Liquid Biopsy Market
Reference Laboratory
The Hospital
Research Center
Other
Based on Types the Market is categorized into Below types that held the largest Liquid Biopsy market share In 2023.
Test Suite
Equipment
Service
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Liquid Biopsy Market Research Analysis
1. Introduction of the Global Liquid Biopsy Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Liquid Biopsy Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Liquid Biopsy Market, By Type
6. Global Liquid Biopsy Market, By Application
7. Global Liquid Biopsy Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Liquid Biopsy Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/